ACT	Anaplastic Thyroid Cancer
BC	Breast Cancer
BCLC	Barcelona Clinic Liver Cancer
CBC	Complete Blood Count
CAR	C-Reactive Protein-to-Albumin Ratio
CRC	Colorectal Cancer
CSS	Cancer-Specific Survival
DFS	Disease-Free Survival
DTC	Differentiated Thyroid Cancer
ESD	Endoscopic Submucosal Dissection
F-NLR	Fibrinogen-Neutrophil-to-Lymphocyte Ratio
HCC	Hepatocellular Carcinoma
HER2	Human Epidermal Growth Factor Receptor 2
HGSC	High-Grade Serous Ovarian Cancer
LC	Lung Cancer
MetS	Metabolic Syndrome
mCRPC	Metastatic Castration-Resistant Prostate Cancer
NACT	Neoadjuvant Chemotherapy
NET	Neutrophil Extracellular Trap
NLR	Neutrophil-to-Lymphocyte Ratio
NLRc	Postoperative NLR/Preoperative NLR
NSCLC	Non-Small Cell Lung Cancer
OS	Overall Survival
PAC	Pancreatic Adenocarcinoma
PDTC	Poorly Differentiated Thyroid Cancer
pCR	Pathological Complete Response
PFS	Progression-Free Survival
PLR	Platelet-to-Lymphocyte Ratio
PSA	Prostate-Specific Antigen
R-NLR	Red Blood Cell Distribution Width - Neutrophil-to-Lymphocyte Ratio
RDW	Red Cell Distribution Width
RCC	Renal Cell Carcinoma
RFS	Relapse-Free Survival
RT	Radiotherapy
SCLC	Small Cell Lung Cancer
TAN	Tumor-Associated Neutrophil